Advancing knowledge of human development, developmental disabilities, and neurodegenerative diseases.
David Gamm received the Visionary Award from the Foundation Fighting Blindness at the Dining in the Dark event.
Read about researchers making major breakthroughs in stem cell work.
For the first time, scientists at the UW-Madison have made early retina structures containing proliferating neuroretinal progenitor cells using induced pluripotent stem (iPS) cells derived from human blood.
Among the many hurdles to be cleared before human embryonic stem cells can achieve their therapeutic potential is determining whether or not transplanted cells can functionally integrate into target organs or tissues.
Soon, some treatments for blinding eye diseases might be developed and tested using retina-like tissues produced from the patient’s own skin, thanks to a series of discoveries reported by a team of University of Wisconsin–Madison stem cell researchers. The team, led by stem cell scientist and ophthalmologist Dr. David Gamm of the UW School of …
Long considered to be little more than putty in the brain and spinal cord, the star-shaped astrocyte has found new respect among neuroscientists who have begun to recognize its many functions in the brain, not to mention its role in a range of disorders of the central nervous system.
Newborn neurons in the adult hippocampus may help form new memories. If so, might neurogenesis play a role in neurological disorders and adult mental retardation? New research into Fragile X syndrome suggests so. This disorder is the most common form of inherited mental retardation, and is caused by a mutation that prevents production of a …
Derek Hei, PhD, director of Waisman Biomanufacturing was quoted extensively in the January 20th issue of the Isthmus.
Waisman Center researcher David M. Gamm, MD, PhD, has been awarded a vision research grant for “The Role of MITF in Early Retinal Fate Determination in Human Embryonic Stem Cells”.
A press conference at the Waisman Center today focused on the many ramifications of the recent decision by a U.S. District Court judge to suspend federal funding for embryonic stem cell research.
